Noble Life Sciences can help accelerate your time to market by providing your diabetes drug with a comprehensive and efficient pre-clinical development program. The quality of our data will enable you to make more informed decisions, faster.

With our cardiovascular training methods, Noble Life Sciences brings comprehensive expertise to the development of these tests. Our medical device division provides surgical expertise and supports utilizing state of the art equipment to better our understanding of cardiovascular disease and injury.

Our diabetes services team has the experience and expertise to conduct high-quality studies that will meet your research objectives and regulatory requirements.

Diabetes services include metabolic cage studies to screen novel compounds, assessment of drug effects on diabetes and diabetic complications, as well as evaluation of efficacy of potential therapies. We have a high availability of animal models that allows us to perform studies more effectively.

Our Team Can Help

Our team of senior scientists have the experience you need to accelerate your preclinical research

We have the experience you need in preclinical models for type 1 and type 2 diabetes studies. Talk to a member of our team to get started.

Learn more about our Therapeutics Services

Resources & White Papers


Mouse Peritonitis/Sepsis Model of MRSA Infection

Mouse Peritonitis/Sepsis Model of MRSA Infection

Noble Life Sciences, in collaboration with ImQuest Biosciences, has optimized the peritonitis/sepsis mouse model to screen for new antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA). The model’s popularity derives from its ease of use with small and expensive animals, short-duration experiments with reproducible infections, and simple end-points.

read more